Cargando…
Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases
Pemphigus and its variants, viz., vulgaris, foliaceous, vegetans, Ig A pemphigus, paraneoplastic pemphigus and Senear-Usher syndrome are rare autoimmune blistering diseases of the skin and/or mucous membranes. The autoantibodies involved in the pathogenesis of pemphigus against desmoglein result in...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303657/ https://www.ncbi.nlm.nih.gov/pubmed/33341209 http://dx.doi.org/10.1016/j.clindermatol.2020.06.006 |
_version_ | 1783548106170695680 |
---|---|
author | Pawar, Manoj Singh, Mehak |
author_facet | Pawar, Manoj Singh, Mehak |
author_sort | Pawar, Manoj |
collection | PubMed |
description | Pemphigus and its variants, viz., vulgaris, foliaceous, vegetans, Ig A pemphigus, paraneoplastic pemphigus and Senear-Usher syndrome are rare autoimmune blistering diseases of the skin and/or mucous membranes. The autoantibodies involved in the pathogenesis of pemphigus against desmoglein result in the breach of the skin and mucosal barrier, which acts as the first line of defence against pathogens. In this paper we underscore the importance of the integumentary system as a shield against the acquisition as well as transmission of SARS-CoV-2 virion. We have also made an attempt to delineate the various treatment modalities available and the viral-drug dynamics involved in choosing the optimum therapeutic modality. |
format | Online Article Text |
id | pubmed-7303657 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73036572020-06-19 Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases Pawar, Manoj Singh, Mehak Clin Dermatol COVID-19: Important Updates and Developments Pemphigus and its variants, viz., vulgaris, foliaceous, vegetans, Ig A pemphigus, paraneoplastic pemphigus and Senear-Usher syndrome are rare autoimmune blistering diseases of the skin and/or mucous membranes. The autoantibodies involved in the pathogenesis of pemphigus against desmoglein result in the breach of the skin and mucosal barrier, which acts as the first line of defence against pathogens. In this paper we underscore the importance of the integumentary system as a shield against the acquisition as well as transmission of SARS-CoV-2 virion. We have also made an attempt to delineate the various treatment modalities available and the viral-drug dynamics involved in choosing the optimum therapeutic modality. Elsevier Inc. 2020 2020-06-19 /pmc/articles/PMC7303657/ /pubmed/33341209 http://dx.doi.org/10.1016/j.clindermatol.2020.06.006 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | COVID-19: Important Updates and Developments Pawar, Manoj Singh, Mehak Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases |
title | Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases |
title_full | Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases |
title_fullStr | Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases |
title_full_unstemmed | Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases |
title_short | Systemic steroids and risk of fecal-oral shedding and increased transmission of SARS-CoV-2 in pemphigus cases |
title_sort | systemic steroids and risk of fecal-oral shedding and increased transmission of sars-cov-2 in pemphigus cases |
topic | COVID-19: Important Updates and Developments |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303657/ https://www.ncbi.nlm.nih.gov/pubmed/33341209 http://dx.doi.org/10.1016/j.clindermatol.2020.06.006 |
work_keys_str_mv | AT pawarmanoj systemicsteroidsandriskoffecaloralsheddingandincreasedtransmissionofsarscov2inpemphiguscases AT singhmehak systemicsteroidsandriskoffecaloralsheddingandincreasedtransmissionofsarscov2inpemphiguscases |